Success Metrics

Clinical Success Rate
93.2%

Based on 41 completed trials

Completion Rate
93%(41/44)
Active Trials
2(4%)
Results Posted
32%(13 trials)
Terminated
3(5%)

Phase Distribution

Ph not_applicable
3
5%
Ph phase_3
12
22%
Ph phase_1
21
38%
Ph phase_4
2
4%
Ph phase_2
16
29%

Phase Distribution

21

Early Stage

16

Mid Stage

14

Late Stage

Phase Distribution54 total trials
Phase 1Safety & dosage
21(38.9%)
Phase 2Efficacy & side effects
16(29.6%)
Phase 3Large-scale testing
12(22.2%)
Phase 4Post-market surveillance
2(3.7%)
N/ANon-phased studies
3(5.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

89.1%

41 of 46 finished

Non-Completion Rate

10.9%

5 ended early

Currently Active

2

trials recruiting

Total Trials

55

all time

Status Distribution
Active(4)
Completed(41)
Terminated(5)
Other(5)

Detailed Status

Completed41
unknown4
Terminated3
Withdrawn2
Recruiting2
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
55
Active
2
Success Rate
93.2%
Most Advanced
Phase 4

Trials by Phase

Phase 121 (38.9%)
Phase 216 (29.6%)
Phase 312 (22.2%)
Phase 42 (3.7%)
N/A3 (5.6%)

Trials by Status

withdrawn24%
terminated35%
suspended12%
completed4175%
recruiting24%
unknown47%
not_yet_recruiting24%

Recent Activity

Clinical Trials (55)

Showing 20 of 55 trialsScroll for more
NCT06429930Phase 1

Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults

Recruiting
NCT07194629Phase 4

Pilot and Feasibility Study of Impact of SDF 38% Application on Oral Health of Elderly With Autonomy Loss

Not Yet Recruiting
NCT04041648Phase 1

Single Ascending Dose Study for Evaluation of Safety, Tolerability and Pharmacokinetics of L606

Completed
NCT04018664Phase 1

Oral Abuse Potential Study of Nalbuphine

Completed
NCT03278730Phase 2

Efficacy of Para-Tyrosine Supplementation on the Survival and Clinical Outcome in Patients With Sepsis

Suspended
NCT05188222Phase 4

Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery

Not Yet Recruiting
NCT00833872Phase 1

LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects

Completed
NCT02175342Phase 2

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT03480971Phase 2

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Recruiting
NCT04250207Phase 2

Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis

Completed
NCT05938946Phase 1

Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults

Completed
NCT01860404Phase 2

BCAA Supplementation for Concussion

Completed
NCT04194645Phase 1

A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink.

Completed
NCT03496623Phase 3

A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)

Terminated
NCT05926245Phase 1

Topical Absorption of Glutathione-cyclodextrin Complex in Healthy Human Subjects Improves Immune Response Against Mycobacterium Infection

Completed
NCT04280003Phase 2

Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke

Unknown
NCT05794802Not Applicable

Ketone Monoester and Blood Pressure

Unknown
NCT00973856Not Applicable

Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands

Completed
NCT03849664Phase 3

Efficacy and Safety of Cytoflavin® Used in Elderly Patients for the Prevention of Cognitive Decline After Major Surgery

Completed
NCT04808544Phase 2

Naldebain for Pain Management of Laparoscopic Cholecystectomy

Completed

Drug Details

Intervention Type
DRUG
Total Trials
55